SAN DIEGO, Nov. 19, 2020 /PRNewswire/ -- Neurocrine
Biosciences, Inc. (Nasdaq: NBIX) today announced that Neurocrine
Biosciences management will present at the following investor
conferences:
- Matt Abernethy, Chief Financial
Officer, and Eiry Roberts, Chief Medical Officer, will present at
the Piper Sandler 32nd Annual Virtual Healthcare
Conference at 10:00 a.m. Eastern Time on
Monday, November 23, 2020.
- Kevin Gorman, Chief Executive
Officer, and Matt Abernethy, Chief
Financial Officer, will present at the Evercore ISI 3rd
Annual HealthCONx Conference at 1:50 p.m.
Eastern Time on Tuesday, December 1, 2020.
The live presentations will be webcast and may be accessed on
the Company's website under Investors at www.neurocrine.com. A
replay of the presentations will be available on the website
approximately one hour after the conclusion of the events and will
be archived for approximately one month.
About Neurocrine Biosciences
Neurocrine Biosciences is
a neuroscience-focused, biopharmaceutical company dedicated to
discovering, developing and delivering life-changing treatments for
people with serious, challenging and under-addressed neurological,
endocrine and psychiatric disorders. The company's diverse
portfolio includes FDA-approved treatments for tardive dyskinesia,
Parkinson's disease, endometriosis*, uterine fibroids* and clinical
programs in multiple therapeutic areas. For nearly three decades,
Neurocrine Biosciences has specialized in targeting and
interrupting disease-causing mechanisms involving the
interconnected pathways of the nervous and endocrine systems. For
more information, visit neurocrine.com, and follow the
company on LinkedIn. (*in collaboration with
AbbVie)
View original content to download
multimedia:http://www.prnewswire.com/news-releases/neurocrine-biosciences-to-present-at-upcoming-healthcare-conferences-301177243.html
SOURCE Neurocrine Biosciences, Inc.